Findings

What do systematic reviews say?

7 questions · 7 findings · 4 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 14.3%GRADE not reported 1 · 14.3%Very low 0 · 0%Low 2 · 28.6%Moderate 3 · 42.9%High 0 · 0%

Magnesium sulphate or magnesium sulphate + salbutamol vs salbutamol

Adverse events · children from 1 month to 24 months old with acute bronchiolitis

1 finding from 1 review

Magnesium sulphate for treating acute bronchiolitis in children up to two years of age 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 56 participants
GRADE not reported

R‐salbutamol 0.5% topical cream vs placebo

Adverse events of medication, leading to discontinuation or significant morbidity · people with discoid lupus erythematosus

1 finding from 1 review

Drugs for discoid lupus erythematosus 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 37 participants
Moderate

Honey vs salbutamol

Adverse events · acute cough in children

The review found no eligible studies for this question.

1 finding from 1 review

Honey for acute cough in children 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Regular salmeterol vs salbutamol

All‐cause non‐fatal serious adverse events ‐ children · patients with chronic asthma

Regular salmeterol showed no clear difference in all‐cause non‐fatal serious adverse events ‐ children compared with regular salbutamol (moderate certainty).

1 finding from 1 review

Regular treatment with salmeterol for chronic asthma: serious adverse events 2008 · Cochrane Headline outcomes only
OR 1.37 [0.71, 2.64]
3 studies · 1181 participants
Moderate

Regular salmeterol vs salbutamol

Asthma‐related non‐fatal serious adverse events ‐ children · patients with chronic asthma

Regular salmeterol showed no clear difference in asthma‐related non‐fatal serious adverse events ‐ children compared with regular salbutamol (low certainty).

1 finding from 1 review

Regular treatment with salmeterol for chronic asthma: serious adverse events 2008 · Cochrane Headline outcomes only
OR 1.04 [0.47, 2.31]
3 studies · 1186 participants
Low

Regular salmeterol vs salbutamol

All‐cause non‐fatal serious adverse events ‐ adults and adolescents · patients with chronic asthma

Regular salmeterol showed no clear difference in all‐cause non‐fatal serious adverse events ‐ adults and adolescents compared with regular salbutamol (moderate certainty).

1 finding from 1 review

Regular treatment with salmeterol for chronic asthma: serious adverse events 2008 · Cochrane Headline outcomes only
OR 0.96 [0.85, 1.1]
5 studies · 27002 participants
Moderate

Regular salmeterol vs salbutamol

Asthma‐related non‐fatal serious adverse events ‐ adults and adolescents · patients with chronic asthma

Regular salmeterol showed no clear difference in asthma‐related non‐fatal serious adverse events ‐ adults and… compared with regular salbutamol (low certainty).

1 finding from 1 review

Regular treatment with salmeterol for chronic asthma: serious adverse events 2008 · Cochrane Headline outcomes only
OR 0.94 [0.37, 2.34]
3 studies · 1155 participants
Low